Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future

Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs f...

Full description

Bibliographic Details
Main Authors: Hyun Young Woo, Jeong Heo
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2015-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Drug eluting beads
Hepatocellular carcinoma
Transarterial chemoembolization
Online Access:http://e-cmh.org/upload/pdf/cmh-21-344.pdf
id doaj-7f2f4265633143f282f54eaabb80216c
record_format Article
spelling doaj-7f2f4265633143f282f54eaabb80216c2020-11-24T23:36:48ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2015-12-0121434434810.3350/cmh.2015.21.4.3441159Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureHyun Young Woo0Jeong Heo1Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Korea.Department of Internal Medicine, College of Medicine, Pusan National University and Medical Research Institute, Pusan National University Hospital, Busan, Korea.Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.http://e-cmh.org/upload/pdf/cmh-21-344.pdfDrug eluting beadsHepatocellular carcinomaTransarterial chemoembolization
collection DOAJ
language English
format Article
sources DOAJ
author Hyun Young Woo
Jeong Heo
spellingShingle Hyun Young Woo
Jeong Heo
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Clinical and Molecular Hepatology
Drug eluting beads
Hepatocellular carcinoma
Transarterial chemoembolization
author_facet Hyun Young Woo
Jeong Heo
author_sort Hyun Young Woo
title Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
title_short Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
title_full Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
title_fullStr Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
title_full_unstemmed Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
title_sort transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: now and future
publisher Korean Association for the Study of the Liver
series Clinical and Molecular Hepatology
issn 2287-2728
2287-285X
publishDate 2015-12-01
description Transarterial chemoembolization (TACE) using doxorubicin-eluting beads (DEBs) have been introduced as a novel device which ensures more sustained and tumor-selective drug delivery and permanent embolization compared to conventional TACE with lipiodol. Studies highlighting the use of TACE with DEBs for the treatment of hepatocellular carcinoma (HCC) have shown similar or better results compared to conventional TACE with lipiodol. TACE with DEBs is increasingly being performed interchangeably with conventional TACE. This review assessed the characteristics, clinical outcomes and future direction of TACE with DEBs compared to conventional TACE.
topic Drug eluting beads
Hepatocellular carcinoma
Transarterial chemoembolization
url http://e-cmh.org/upload/pdf/cmh-21-344.pdf
work_keys_str_mv AT hyunyoungwoo transarterialchemoembolizationusingdrugelutingbeadsforthetreatmentofhepatocellularcarcinomanowandfuture
AT jeongheo transarterialchemoembolizationusingdrugelutingbeadsforthetreatmentofhepatocellularcarcinomanowandfuture
_version_ 1725521555528613888

Similar Items